Matches in Nanopublications for { ?s ?p "[Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP456434.RAk-ela5UMJwMSbh-uv7ZjX8QB3A-rak-ndCRyqNt8r3Q130_assertion description "[Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP456434.RAk-ela5UMJwMSbh-uv7ZjX8QB3A-rak-ndCRyqNt8r3Q130_provenance.
- NP835983.RA4h35V_pYAR6O_qt912kcPKSx65b94h-qIorS9O32uig130_assertion description "[Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP835983.RA4h35V_pYAR6O_qt912kcPKSx65b94h-qIorS9O32uig130_provenance.
- NP519788.RAAyYdCExJ88dFDDlceM_Vhwsus2xsopkvmNtJMlCWmhw130_assertion description "[Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519788.RAAyYdCExJ88dFDDlceM_Vhwsus2xsopkvmNtJMlCWmhw130_provenance.
- NP797023.RABPn42IsagFFhiwIDdHu3_u_eIHo0C8ocGquKIhkrnqc130_assertion description "[Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797023.RABPn42IsagFFhiwIDdHu3_u_eIHo0C8ocGquKIhkrnqc130_provenance.
- assertion description "[Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP797020.RATJAphSiXu5ASFjnNCauaxUSCuDhT1hgWXURrYcNWZiE130_assertion description "[Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797020.RATJAphSiXu5ASFjnNCauaxUSCuDhT1hgWXURrYcNWZiE130_provenance.
- NP519108.RAHStdo2kK_hDT0ynKU0qlqMObDmWQHHhe7TJ9xOLEBqQ130_assertion description "[Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519108.RAHStdo2kK_hDT0ynKU0qlqMObDmWQHHhe7TJ9xOLEBqQ130_provenance.
- assertion description "[Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP797022.RAOqUL1G3bsiWsTD2mm0vXRDIJewCrCtnSaXKmFAQaJXo130_assertion description "[Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797022.RAOqUL1G3bsiWsTD2mm0vXRDIJewCrCtnSaXKmFAQaJXo130_provenance.